Journals / Türk Oftalmoloji Dergisi / 2009 / Cilt: 39 - Sayı: 4

Comparison of efficacy limbal conjunctival autograft for treatment of primary and recurrent pterygium

Primer ve rekürren pterjiumda limbal konjonktival otogreft ile tedavi etkinliğinin karşılaştırılması

Pages
256–261
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Having high success and low complication rates limbal conjunctival autograft is an effective method in the treatment of both primary pterygia and recurrent pterygia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The efficacy of limbal conjunctival autograft transplantation for primary and for recurrent pterygia were compared.
📊
Key Findings & Data:Material and Methods: Thirty eyes with primary and 35 eyes with recurrent pterygia were included in this study.
💡
Conclusion & Impact:Discussion: Having high success and low complication rates limbal conjunctival autograft is an effective method in the treatment of both primary pterygia and recurrent pterygia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The efficacy of limbal conjunctival autograft transplantation for primary and for recurrent pterygia were compared. Material and Methods: Thirty eyes with primary and 35 eyes with recurrent pterygia were included in this study. Mean age was 56,30 ± 16,06 years, and mean follow-up time was 16,16 ± 3,30 months in the primary pterygia group. 15 patients (50%) were female and 15 of them (50%) were male. In recurrent pterygia group mean age was 55,54 ± 13,87 years and the mean follow-up time was 16,80 ± 3,06 months. 23 of these patients (65,7%) were female and 12 of them (34,3%) were male. Both groups were compared for recurrence of pterygia and complications. Results: No statistically significant differences were found between two groups in age, gender and duration of follow-up. Two recurrences (6,7%) were observed in primary pterygia group whereas no recurrence was observed in recurrent pterygia group. No other complications were observed. The difference of efficacy of limbal conjunctival autograft between both groups was statistically not significant (p>0,05). Discussion: Having high success and low complication rates limbal conjunctival autograft is an effective method in the treatment of both primary pterygia and recurrent pterygia.

Özet

Amaç: Limbal konjonktival otogreft transplantasyonunun etkinliği primer ve rekürren pterjium olgularında karşılaştırıldı. Yöntem: Primer pterjiumlu 30 ve rekürren pterjiumlu 35 göz çalışma kapsamına alındı. Primer pterjiumlu gruptaki yaş ortalaması 56,30 ± 16,06, takip süresi 16,16 ± 3,30 ay idi. Hastaların 15’i (%50) erkek, 15’i (%50) kadın idi. Rekürren pterjiumu olan grupta yaş ortalaması 55,54 ± 13,87, takip süresi 16,80 ± 3,06 aydı. Hastaların 23’ü (%65,7) erkek, 12’si (%34,3) kadın idi. İki grup, pterjium nüksü ve komplikasyonlar açısından karşılaştırıldı. Sonuçlar: Primer ve rekürren pterjiumlu iki grup arasında yaş, cinsiyet ve takip süresi açısından istatistiksel fark bulunmadı. Primer pterjiumlu grupta 2 (%6,7) nüks izlenirken rekürren pterjiumlu grupta pterjium nüksü olmadı. Bunun dışında bir komplikasyonla karşılaşılmadı. İki grup arasında limbal konjonktival otogreft tekniğinin etkinliği istatistiksel olarak anlamlı değildi (p>0,05). Tartışma: Hem rekürren hem de primer pterjium tedavisinde limbal konjonktival otogreft yüksek başarı ve düşük komplikasyon oranlarıyla etkin bir yöntemdir.

🔖

Cite This Article

KOCAOĞLU, A. F., DİKÇİ, S., TÖK, Ö. Y., ÖRNEK, F., BURCU, A. (2022). Comparison of efficacy limbal conjunctival autograft for treatment of primary and recurrent pterygium. Türk Oftalmoloji Dergisi, Cilt: 39 - Sayı: 4, 256–261. https://ajindex.com/articles/638524

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Coronco MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999; 10:282-288
  2. Caliskan S. Orhan M, Irkce M. Intraoperative mitomycin C for pterygium surgery. Ophthalmology 1999; 106:208-209
  3. Luanratanakorn P. Ratanapakorn T. Suwan-Apichon O. Chuck RS. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br J Ophthalmol 2006; 90:1476-1480
  4. Adam is AP. Starck T, Kenyon KR. The management of pterygium. Ophthalmol Clin North Am 1990; 3:611-623
  5. Mackenzie FD, Hirst LW, Battistutta D, Green A. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology 1992; 99:1056-1061
  6. Chowcrs I, Pe'cr J. Zamii K. Lıvni N. Usui M, Fıuclıı-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001: 108:985-988
  7. Ünal M. Durmuş M. Biryılmaz A. Primer ve rekürren pterjium cerrahisinde limbal konjonktival otogreft uygulaması. T Klin Oftalmoloji 1999; 8:37-42
  8. Demirciler T, Durak İ. Gürsel E. Güven H. Primer ve rekürren pterjium tedavisinde mitomycin C. T Klin Oftalmoloji 1992; 1:329-331
  9. Rosenthal JW. Chronology of pterygium therapy. Am J Ophthalmol 1953;36:1601-1616
  10. Klcis W. Pico G. Thio-tcpa therapy to prevent postopera-tif pterygium occurrence and neovascularization. Am J Ophthalmol 1973; 76:371-373
  11. Insler MS and Caldwell DR. Peripheral disease (Terrien s and recurrent pterygium). In: Brightbill FS, ed. Corneal surgery: Theory, Technique, and Tissue. St Louis: CV Mosby, 1986:387-395
  12. Bekibele CO. Baiycroju AM, Ajayi BG. 5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence. Int J Clin Pract 2004; 58:920-923
  13. Singh G. Wilson MR. Foster CS. Mitomycin eye drops as treatment lor pterygium. Ophthalmology 1988; 95:813-821
  14. Apaydın KC. Duranoglu Y. Saka O. Demirbaş N. Argon laser treatment of pterygium. Ann Ophthalmol 2002: 34:26-29
  15. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol 1980: 64:496-505
  16. Mackenzie FD, Hirst LW. Kynaston B. Bain C. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology 1991: 98:1776-1780: discussion 1781
  17. Rubinfcld RS. Pfisier RR. Stein RM. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992:99:1647-1654
  18. Kenyon KK. Wagoner MD. Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. O